✦ LIBER ✦

Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer

✍ Scribed by Taekyu Lim; Jeeyun Lee; Duk Joo Lee; Ha Yeon Lee; Boram Han; Kyung Kee Baek; Hee Kyung Ahn; Su Jin Lee; Se Hoon Park; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Kyoung-Mee Kim; Won Ki Kang

Publisher: Springer
Year: 2011
Tongue: English
Weight: 313 KB
Volume: 68
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-011-1653-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of oral metronomic vinor

A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer

✍ Zacharenia Saridaki; Nikolaos Malamos; Panagiotis Kourakos; Aristides Polyzos; A 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 294 KB

Phase I trial of dose escalation of cape

Phase I trial of dose escalation of capecitabine combined with fixed docetaxel in previously treated patients with non-small cell lung cancer

✍ Qiang Lin; Yue’e Liu; Chuilin Chang; Na Wang; Jingmei Fu; Xiaocang Ren; Xueji Ch 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 260 KB

Phase II study of ifosfamide plus vinore

Phase II study of ifosfamide plus vinorelbine in metastatic breast cancer patients previously treated with combination chemotherapy

✍ F. Lobo; A. Frau; A. Barnadas; M. Méndez; J. Lizón; M. Provencio; J. J. Albistur 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 73 KB

Phase III randomized trial of sunitinib

Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer

✍ Carlos H. Barrios; Mei-Ching Liu; Soo Chin Lee; Laurence Vanlemmens; Jean-Marc F 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 289 KB

Phase I study of cediranib in combinatio

Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer

✍ Taroh Satoh; Yasuhide Yamada; Kei Muro; Hidetoshi Hayashi; Yasuhiro Shimada; Dai 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 241 KB

Phase 2 trial of talactoferrin in previo

Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma

✍ Eric Jonasch; Walter M. Stadler; Ronald M. Bukowski; Teresa G. Hayes; Atul Varad 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

## Abstract ## BACKGROUND. Talactoferrin (TLF), a recombinant form of human lactoferrin (hLF), is an immunomodulatory iron‐binding glycoprotein first identified in breast milk. Its immunomodulatory functions include activation of natural killer (NK) and lymphokine‐activated killer cells and enhanc